Provided by Tiger Trade Technology Pte. Ltd.

Biofrontera Inc Warrant

0.0050
0.0000
Post-market: 0.00500.00000.00%19:52 EDT
Volume:11.86K
Turnover:61.03
Market Cap:53.34K
PE:0.00
High:0.0052
Open:0.0051
Low:0.0050
Close:0.0050
52wk High:0.1484
52wk Low:0.0050
Shares:10.67M
Float Shares:10.67M
Volume Ratio:1.98
T/O Rate:0.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8444
ROE:-325.31%
ROA:-35.18%
PB:0.00
PE(LYR):- -

Loading ...

Company Profile

Company Name:
Biofrontera Inc Warrant
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Website:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. It offers Ameluz, a prescription drug for use in combination with the RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company also provides Xepi, a topical non-fluorinated quinolone that inhibits bacterial growth for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.